Porth Ymchwil

Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis. / Sandoo, A; Panoulas, V F; Toms, T E et al.
Yn: Journal of human hypertension, Cyfrol 25, Rhif 11, 11.2011, t. 699-702.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Sandoo, A, Panoulas, VF, Toms, TE, Smith, JP, Stavropoulos-Kalinoglou, A, Metsios, GS, Gasparyan, AY, Carroll, D, Veldhuijzen van Zanten, JJCS & Kitas, GD 2011, 'Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis', Journal of human hypertension, cyfrol. 25, rhif 11, tt. 699-702. https://doi.org/10.1038/jhh.2011.36

APA

Sandoo, A., Panoulas, V. F., Toms, T. E., Smith, J. P., Stavropoulos-Kalinoglou, A., Metsios, G. S., Gasparyan, A. Y., Carroll, D., Veldhuijzen van Zanten, J. J. C. S., & Kitas, G. D. (2011). Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis. Journal of human hypertension, 25(11), 699-702. https://doi.org/10.1038/jhh.2011.36

CBE

Sandoo A, Panoulas VF, Toms TE, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS, Gasparyan AY, Carroll D, Veldhuijzen van Zanten JJCS, Kitas GD. 2011. Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis. Journal of human hypertension. 25(11):699-702. https://doi.org/10.1038/jhh.2011.36

MLA

Sandoo, A et al. "Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis". Journal of human hypertension. 2011, 25(11). 699-702. https://doi.org/10.1038/jhh.2011.36

VancouverVancouver

Sandoo A, Panoulas VF, Toms TE, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS et al. Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis. Journal of human hypertension. 2011 Tach;25(11):699-702. doi: 10.1038/jhh.2011.36

Author

Sandoo, A ; Panoulas, V F ; Toms, T E et al. / Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis. Yn: Journal of human hypertension. 2011 ; Cyfrol 25, Rhif 11. tt. 699-702.

RIS

TY - JOUR

T1 - Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis

AU - Sandoo, A

AU - Panoulas, V F

AU - Toms, T E

AU - Smith, J P

AU - Stavropoulos-Kalinoglou, A

AU - Metsios, G S

AU - Gasparyan, A Y

AU - Carroll, D

AU - Veldhuijzen van Zanten, J J C S

AU - Kitas, G D

PY - 2011/11

Y1 - 2011/11

KW - Adalimumab

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Antirheumatic Agents

KW - Arthritis, Rheumatoid

KW - Blood Pressure

KW - Endothelium, Vascular

KW - England

KW - Etanercept

KW - Humans

KW - Immunoglobulin G

KW - Inflammation Mediators

KW - Infliximab

KW - Longitudinal Studies

KW - Microvessels

KW - Receptors, Tumor Necrosis Factor

KW - Time Factors

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

KW - Letter

KW - Research Support, Non-U.S. Gov't

U2 - 10.1038/jhh.2011.36

DO - 10.1038/jhh.2011.36

M3 - Article

C2 - 21525886

VL - 25

SP - 699

EP - 702

JO - Journal of human hypertension

JF - Journal of human hypertension

SN - 0950-9240

IS - 11

ER -